Wang X - Search Results

1

Efficacy Evaluation of Imatinib for the Treatment of Melanoma: Evidence From a Retrospective Study.

Wei X, Mao L, Chi Z, Sheng X, Cui C, Kong Y, Dai J, Wang X, Li S, Tang B, Lian B, Yan X, Bai X, Zhou L, Guo J, Si L. Wei X, et al. Among authors: wang x. Oncol Res. 2019 Mar 29;27(4):495-501. doi: 10.3727/096504018X15331163433914. Epub 2018 Aug 3. Oncol Res. 2019. PMID: 30075827 Free PMC article.

2

[Impact of sequential targeted therapy on progression-free survival in metastatic renal cell carcinoma].

Si L, Bai X, Mao L, Wang X, Chi Z, Cui C, Sheng X, Tang B, Guo J. Si L, et al. Among authors: wang x. Zhonghua Yi Xue Za Zhi. 2014 Sep 9;94(33):2580-3. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25511488 Chinese.

3

[Genetic polymorphisms of PDGFR associated with thrombocytopenia in Chinese patients with clear-cell metastatic renal cell carcinoma treated with sunitinib].

Sheng X, Kong Y, Tang H, Lian B, Mao L, Chi Z, Cui C, Si L, Wang X, Yan X, Li S, Dai J, Guo J. Sheng X, et al. Among authors: wang x. Zhonghua Yi Xue Za Zhi. 2014 Oct 21;94(38):2988-91. Zhonghua Yi Xue Za Zhi. 2014. PMID: 25547700 Chinese.

4

Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patients.

Sheng X, Li S, Chi Z, Si L, Cui C, Mao L, Lian B, Tang B, Wang X, Yan X, Kong Y, Dai J, Guo J. Sheng X, et al. Among authors: wang x. Br J Ophthalmol. 2015 Jul;99(7):990-6. doi: 10.1136/bjophthalmol-2014-305730. Epub 2015 Jan 16. Br J Ophthalmol. 2015. PMID: 25595173

5

Genotyping of mucosal melanoma.

Si L, Wang X, Guo J. Si L, et al. Among authors: wang x. Chin Clin Oncol. 2014 Sep;3(3):34. doi: 10.3978/j.issn.2304-3865.2014.07.03. Chin Clin Oncol. 2014. PMID: 25841460 Free article.

6

Treatment algorithm of metastatic mucosal melanoma.

Wang X, Si L, Guo J. Wang X, et al. Chin Clin Oncol. 2014 Sep;3(3):38. doi: 10.3978/j.issn.2304-3865.2014.08.04. Chin Clin Oncol. 2014. PMID: 25841464 Free article.

7

[A pilot study of sunitinib as first-line therapy for metastatic renal cell carcinoma on a 2 weeks on/1 week off intermittent dosing schedule].

Cui C, Li S, Chi Z, Si L, Sheng X, Mao L, Lian B, Wang X, Tang B, Guo J. Cui C, et al. Among authors: wang x. Zhonghua Zhong Liu Za Zhi. 2015 May;37(5):375-8. Zhonghua Zhong Liu Za Zhi. 2015. PMID: 26463030 Chinese.

8

[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma].

Tang B, Chi Z, Sheng X, Cui C, Si L, Kong Y, Li S, Mao L, Lian B, Wang X, Yan X, Guo J. Tang B, et al. Among authors: wang x. Zhonghua Yi Xue Za Zhi. 2015 Aug 11;95(30):2459-61. Zhonghua Yi Xue Za Zhi. 2015. PMID: 26711209 Chinese.

9

Efficacy and safety of sorafenib versus sunitinib as first-line treatment in patients with metastatic renal cell carcinoma: largest single-center retrospective analysis.

Sheng X, Chi Z, Cui C, Si L, Li S, Tang B, Mao L, Lian B, Wang X, Yan X, Guo J. Sheng X, et al. Among authors: wang x. Oncotarget. 2016 May 10;7(19):27044-54. doi: 10.18632/oncotarget.7395. Oncotarget. 2016. PMID: 26894858 Free PMC article.

10

GNAQ and GNA11 mutations occur in 9.5% of mucosal melanoma and are associated with poor prognosis.

Sheng X, Kong Y, Li Y, Zhang Q, Si L, Cui C, Chi Z, Tang B, Mao L, Lian B, Wang X, Yan X, Li S, Dai J, Guo J. Sheng X, et al. Among authors: wang x. Eur J Cancer. 2016 Sep;65:156-63. doi: 10.1016/j.ejca.2016.06.019. Epub 2016 Aug 4. Eur J Cancer. 2016. PMID: 27498141

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210,617 results

Search Page

Filters